[HTML][HTML] Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation

M Zhang, Z Tang - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disease mainly characterized by
progressive cognitive dysfunction and memory impairment. Recent studies have shown that …

Nutraceutical based SIRT3 activators as therapeutic targets in Alzheimer's disease

M Govindarajulu, S Ramesh, L Neel, M Fabbrini… - Neurochemistry …, 2021 - Elsevier
Alzheimer's disease (AD) is the most common neurodegenerative disease, and its incidence
is increasing worldwide with increased lifespan. Currently, there is no effective treatment to …

[HTML][HTML] The role of sirtuin 1 (SIRT1) in neurodegeneration

DI Razick, M Akhtar, J Wen, M Alam, N Dean… - Cureus, 2023 - ncbi.nlm.nih.gov
Sirtuins (SIRT) are a class of histone deacetylases that regulate important metabolic
pathways and play a role in several disease processes. Of the seven mammalian homologs …

A comprehensive analysis into the therapeutic application of natural products as SIRT6 modulators in Alzheimer's disease, aging, cancer, inflammation, and diabetes

R Akter, A Afrose, MR Rahman, R Chowdhury… - International journal of …, 2021 - mdpi.com
Natural products have long been used as drugs to treat a wide array of human diseases.
The lead compounds discovered from natural sources are used as novel templates for …

Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer's disease from bench to bedside

F Islam, MH Nafady, MR Islam, S Saha, S Rashid… - Molecular …, 2022 - Springer
Alzheimer's disease (AD) is the most common cause of dementia and cognitive impairment;
yet, there is currently no treatment. A buildup of Aβ, tau protein phosphorylation, oxidative …

SIRT1 pathway in Parkinson's disease: a faraway snapshot but so close

GES Batiha, HM Al-Kuraishy, AI Al-Gareeb… - …, 2023 - Springer
Silent information regulator (SIRT) has distinctive enzymatic activities and physiological
functions to control cell-cycle progression, gene expression, and DNA stability by targeting …

Blocking SIRT1 inhibits cell proliferation and promotes aging through the PI3K/AKT pathway

H Li, R Wang - Life sciences, 2017 - Elsevier
Aims Alzheimer's disease (AD) is the most prevalent age-related disease and the most
common cause of dementia in the elderly. Its hallmark neuropathological features are the …

Sirt‐1 regulates physiological process and exerts protective effects against oxidative stress

L Liu, G Xia, P Li, Y Wang… - BioMed Research …, 2021 - Wiley Online Library
Background. Recent studies suggest a correlation between the reduced Sirt‐1 expression
with Alzheimer's diseases (AD) and depression, respectively, suggesting a possible …

A promising strategy to treat neurodegenerative diseases by SIRT3 activation

A Tyagi, S Pugazhenthi - International Journal of Molecular Sciences, 2023 - mdpi.com
SIRT3, the primary mitochondrial deacetylase, regulates the functions of mitochondrial
proteins including metabolic enzymes and respiratory chain components. Although SIRT3's …

SIRT1 as a therapeutic target for Alzheimer's disease

SY Wong, BL Tang - Reviews in the Neurosciences, 2016 - degruyter.com
Alzheimer's disease (AD) is the most prevalent cause of dementia in the aging population
worldwide. SIRT1 deacetylation of histones and transcription factors impinge on multiple …